This is a news story, published by Live Science, that relates primarily to Guillain-Barré news.
For more Guillain-Barré news, you can click here:
more Guillain-Barré newsFor more vaccine development news, you can click here:
more vaccine development newsFor more news from Live Science, you can click here:
more news from Live ScienceOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
RSV vaccine coverage. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest RSV vaccines news, RSV vaccination news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
RSV vaccineLive Science
•80% Informative
The CDC has narrowed its recommendations for which older adults should get a vaccine against respiratory syncytial virus ( RSV ) It now states that only adults 75 and older, or those ages 60 to 74 who are at high risk, should get the shot.
The updated recommendations were issued because of higher-than-expected rates of Guillain-Barré syndrome ( GBS ) GBS is a rare side effect that can sometimes lead to paralysis or death.
VR Score
90
Informative language
94
Neutral language
55
Article tone
formal
Language
English
Language complexity
50
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
5
Source diversity
3